Jinxin Fertility Group Limited

Equities

1951

KYG5140J1013

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 01:38:39 28/05/2024 pm IST			5-day change	1st Jan Change
3.27 ^HKD	-2.68%		-2.39%	-2.39%

27/03	Jinxin Fertility Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03	Jinxin Fertility Group Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2023	CI

Tranche Update on Jinxin Fertility Group Limited's Equity Buyback Plan announced on September 23, 2020.

September 24, 2021 at 01:35 pm IST

From January 1, 2021 to June 29, 2021, the company has repurchased 0 shares, representing 0% for HKD 0 million. With this, the company has completed the repurchase of 1,918,000 shares, representing 0.08% for HKD 18.67 million under the buyback announced on September 23, 2020.

Latest news about Jinxin Fertility Group Limited

Jinxin Fertility Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03	CI
Jinxin Fertility Group Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2023	15/03	CI
Nomura Adjusts Jinxin Fertility Group’s Price Target to HK$6.24 From HK$8.20, Keeps at Buy	28/02	MT
Innovent Biologics Names New CFO	05/02	MT
Jinxin Fertility Group Limited Announces Changes in Address	18/01	CI
Jinxin Fertility CFO Resigns; Successor Named	03/01	MT
Jinxin Fertility Group Limited Announces Change of Chief Financial Officer	02/01	CI
Jinxin Fertility Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Nomura Adjusts Jinxin's Price Target to HK$8.20 From HK$8.90, Keeps at Buy	31/23/31	MT
Jinxin Fertility Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Nomura Adjusts Jinxin Fertility’s Price Target to HK$8.90 From HK$8.71, Keeps at Buy	13/23/13	MT
Jinxin Fertility Completes Share Issuance, Placement	17/23/17	MT
Jinxin Fertility to Raise HK$1.16 Billion From Share Placement	05/23/05	MT
Jinxin Fertility Group Completes Restructuring	02/23/02	MT
Nomura Adjusts Jinxin Fertility’s Price Target to HK$8.71 From HK$9.23, Keeps at Buy	01/22/01	MT
Jinxin Fertility Group Logs Higher H1 Profit	01/22/01	MT
Jinxin Fertility Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31/22/31	CI
Nomura Adjusts Jinxin Fertility Group's Price Target to HK$9.23 From HK$9.80, Keeps at Buy	09/22/09	MT
Jinxin Fertility Group Completes Acquisition of Equity Interests in Kangzhi Hospital, Guangzhou Yunzhicai, Guangzhou Hejia; Shares Climb 6%	14/22/14	MT
Nomura Adjusts Jinxin Fertility Group's Price Target to HK$9.8 From HK$12.4, Keeps at Buy	31/22/31	MT
Jinxin Fertility Group Limited Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI
Beijing Adds Fertility Treatment in Medical Insurance Program; Fertility Pharma Stocks Jump	22/22/22	MT
Jinxin Fertility Arm to Pay Over $273 Million for Shenzhen Hospital Project	07/22/07	MT
Jinxin Fertility Boosts Ownership in Urological Hospital with $45 Million Deal	28/22/28	MT
Jinxin Fertility Group Limited commences an Equity Buyback Plan for 250,758,380 shares, representing 10% of its issued share capital, under the authorization approved on June 29, 2021.	21/21/21	CI

Chart Jinxin Fertility Group Limited

Duration

Period

More charts

Company Profile

Jinxin Fertility Group Limited is a China-based company principally engaged in the provision of assisted reproductive services (ARS). The Company operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The Company mainly operates its business in China and the Unites.

Sector

Healthcare Facilities & Services

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jinxin Fertility Group Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.117 CNY

Average target price

4.575 CNY

Spread / Average Target

+46.75%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
JINXIN FERTILITY GROUP LIMITED	-2.39%	118.68Cr
HCA HEALTHCARE, INC.	+17.37%	8.35TCr
CVS HEALTH CORPORATION	-30.24%	6.97TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-3.24%	2.64TCr
FRESENIUS SE & CO. KGAA	+3.92%	1.79TCr
LABCORP HOLDINGS INC.	-12.33%	1.68TCr
QUEST DIAGNOSTICS INCORPORATED	+2.20%	1.57TCr
NATERA, INC.	+75.67%	1.34TCr
TENET HEALTHCARE CORPORATION	+72.59%	1.28TCr
REDE D'OR SÃO LUIZ S.A.	-0.87%	1.24TCr

Other Healthcare Facilities & Services